Oxygenta Pharmaceutical shareholding pattern
OXYGENTAPH
52
0.00 (0.00%)Last updated on 20 Feb, 2026 | 15:27 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Oxygenta Pharmaceutical reports the following shareholding: Total Promoters at 55.93%, Mutual Fund at 0.03%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 44.04%. This breakdown provides a quick snapshot of ownership distribution for Oxygenta Pharmaceutical in 2025-26.
Oxygenta Pharmaceutical FAQs
As of 02-2026, the promoter shareholding in Oxygenta Pharmaceutical stands at 55.93% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Oxygenta Pharmaceutical is 0% and 0% respectively.
The retail shareholding of the Oxygenta Pharmaceutical is 44.04%.
Changes in shareholding patterns of Oxygenta Pharmaceutical can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Oxygenta Pharmaceutical are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Oxygenta Pharmaceutical Associated Pages
